CCL7 and infection: Second, the murine data suggest that CCL7-blockade may be a useful therapeutic strategy to reduce inflammatory cell infiltration into the kidneys, thereby ameliorating AKI, without affecting systemic mobilization of myeloid cells that may be helpful for defense against infections.